<SEC-DOCUMENT>0001144204-18-034896.txt : 20180620
<SEC-HEADER>0001144204-18-034896.hdr.sgml : 20180620
<ACCEPTANCE-DATETIME>20180620060515
ACCESSION NUMBER:		0001144204-18-034896
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180620
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180620
DATE AS OF CHANGE:		20180620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		18908593

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv496827_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT
REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date of report (Date
of earliest event reported): June 20, 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>STAAR
Surgical Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Exact Name of Registrant
as Specified in Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0-11634</FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95-3797439</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State or Other Jurisdiction <BR>
of Incorporation)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission <BR>
File Number)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S. Employer <BR>
Identification No.)</B></FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>1911
    Walker Ave., Monrovia, California</U></FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>91016&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address of Principal Executive Offices)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 149pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>Registrant&rsquo;s Telephone Number, Including
Area Code <U>626-303-7902&#9;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; border-bottom: Black 1pt solid">Not Applicable&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>(Former Name or Former Address, if Changed Since
Last Report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 5pt">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I>
General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.6pt"><FONT STYLE="font-family: Wingdings">&uml; </FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Written communication pursuant to Rule 425 under the Securities Act (17
CFR 230.425)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.6pt"><FONT STYLE="font-family: Wingdings">&uml; </FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.6pt"><FONT STYLE="font-family: Wingdings">&uml; </FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.6pt"><FONT STYLE="font-family: Wingdings">&uml; </FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 5pt">Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5pt">Emerging growth company <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.6pt 0pt 5pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.6pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.6pt 0pt 5pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.6pt 0pt 5pt"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 7.01</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation FD Disclosure.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 20, 2018, STAAR Surgical Company
issued a press release announcing receipt of a letter from the U.S. Food and Drug Administration lifting a Warning Letter dated
May 21, 2014. A copy of the press release is furnished as Exhibit 99.1 to this Report and is incorporated herein by this reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information furnished herewith pursuant
to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be &ldquo;filed&rdquo; for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities
of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under
the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless
of any general incorporation language in the filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 9.01</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statements and Exhibits</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><A HREF="tv496827_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="font-size: 10pt"><A HREF="tv496827_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated June 20, 2018.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STAAR Surgical Company&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 20, 2018</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>/s/ Caren Mason</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caren Mason</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.6pt 0pt 5pt">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv496827_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Courier; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 45.75pt; width: 201pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STAAR Surgical Announces Resolution of
FDA Warning Letter</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MONROVIA, CA, June 20, 2018</B>---STAAR Surgical Company
(NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye
announced today that it received a close-out letter from the U.S. Food and Drug Administration (FDA) on June 19, 2018 lifting a
Warning Letter dated May 21, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The lifting of the Warning Letter is the result of a
comprehensive remediation program that not only addressed the issues raised by the FDA in the 2014 Warning Letter, but included
the assessment, remediation and upgrade of all aspects of STAAR&rsquo;s quality systems to assure compliance with Quality System
Regulations (QSR),&rdquo; said Caren Mason, President and CEO. &ldquo;We have steadfastly initiated and promoted a <I>Culture of
Quality </I>which emphasizes prevention and accountability throughout the organization. We are committed to continuing and strengthening
this companywide emphasis on excellence&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>About STAAR Surgical</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR, which has been dedicated solely to ophthalmic surgery
for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact
lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR&rsquo;s lens
used in refractive surgery is called an Implantable Collamer&reg; Lens or &ldquo;ICL,&rdquo; which includes the EVO Visian ICL&trade;
product line. More than 800,000 Visian ICLs have been implanted to date. To learn more about the ICL go to: <U>www.discovericl.com</U>.
STAAR has approximately 350 full-time equivalent employees and markets lenses in over 75 countries. Headquartered in Monrovia,
CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the
Company&rsquo;s website at www.staar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Safe Harbor</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements in this press release that are not statements
of historical fact are forward-looking statements, including statements about any of the following: compliance with QSR and any
assumptions underlying or related thereto. Important factors that could cause actual results to differ materially from those indicated
by such forward-looking statements are set forth in the Company&rsquo;s Annual Report on Form 10-K for the year ended December
29, 2017 under the caption &ldquo;Risk Factors,&rdquo; which is on file with the Securities and Exchange Commission and available
in the &ldquo;Investor Information&rdquo; section of the company&rsquo;s website under the heading &ldquo;SEC Filings.&rdquo; We
disclaim any intention or obligation to update or revise any financial projections or forward-looking statement due to new information
or events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These statements are based on expectations and assumptions as
of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ
materially from those described in the forward-looking statements. The risks and uncertainties include the following: the discretion
of regulatory agencies to approve or reject existing, new or improved products, or to require additional actions before approval
(including but not limited to FDA requirements regarding the Visian Toric ICL).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1.5in; text-align: left">CONTACT:</TD><TD STYLE="text-align: justify"><B>Investors &amp; Media:</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">EVC Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Brian Moore, 310-579-6199</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Doug Sherk, 415-652-9100</P>



<P STYLE="margin: 0; text-align: right"><BR>
</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40&3 P$1  (1 0,1 ?_$ +4  0 !! ,  P
M       ) 0<("@(%!@,$"P$!  ,  P$!              $" P0&!P4($
M!@(" 0,"! $'!@\    ! @,$!08 !Q$("2$2$S$402(5"E%A<9&Q,B06\(%"
M([87H<%B5"5UM38G=QB(.7DZ$0 " 0(% @,& @@%!0       0(1 R$Q$@0%
M009180?P<8$B,A.AP9&Q0E)B<B,4T>&"%0@S0R0T%O_:  P# 0 "$0,1 #\
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MZI^3+BE4*< $H_V@Y#T^H<\9QDFZTZ'U=2IC@WT>#_1F<\@D8!03 'IZC_,
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M] X'53<%]J9Q Q3 (\:8KZLC*3M91J;(1?4I?Y0#^K(2JZ&3/SP?(EYD._\
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MQ@R=G>G.[IS06X+!56R3*LW=W%"Y"'N,>Q;%391[J3!@Y3<HH%31$Z!52)I
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M;+GX(DJ8##Z!QD_%>WP*/3TJ3/Y5^61 P!@# & , 8!\9DBF'D>>?;[>>?\
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M50 <8(2H,$E.,5(<4RN"5@4XR:D:45R"1@# :J4 .,$)4*B'. U4 '&"4J#
M& , 8 P!@ 0YP0U4IP'\O].34C2O,J <9!9*@P!@# & , 8 P!@%!#G!#297
M!*5,!@# & , ?7 :J #C!"5!@D8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
E@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
